Cluster Analysis to Identify Metabolic Syndrome Components and Physical Fitness in Patients With Metabolic Syndrome
NCT ID: NCT05569642
Last Updated: 2024-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
112 participants
OBSERVATIONAL
2022-06-13
2023-12-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome)
NCT05702437
Determination Physical Activity Levels,Quality Life,Depression and Fatigue Severity Individuals With Metabolic Syndrome
NCT05184634
Investigation of Respiratory Functions, Exercise Endurance and Functional Capacity in Geriatric Individuals With Metabolic Syndrome
NCT06253819
Metabolomics Predictors for Metabolic Disease Remission After Metabolic Syndrome Surgery.
NCT06645730
Link Between Biochemical, Anthropometric Variables and CD36 in Metabolic Syndrome After a Low-calorie Diet
NCT06881706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Finding abdominal obesity component according to TURDEP-II criteria
* Being between the ages of 40-65
* To be able to read and write Turkish
* Having signed the informed consent form
Exclusion Criteria
* Those with severe peripheral or central neurological disorders
* Patients with uncontrolled hypertension and uncontrolled arrhythmia
* Pregnant or breastfeeding patients
* Those with diabetic ulcer or neuropathy
* Chronic kidney failure (eGFR\<30 ml/min)
* Chronic liver disease (ALT/AST\<3X Normal upper limit)
* Those with serious respiratory system disease
* Patients with cardiac pacemaker
* History of previous stroke or myocardial infarction
* Presence of lower and upper extremity orthopedic problems that may prevent the application of clinical tests
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Galata University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Department of Endocrinology and Metabolic Diseases
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IstanbulGalataUni
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.